These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11756176)

  • 1. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
    Bladergroen BA; Meijer CJ; ten Berge RL; Hack CE; Muris JJ; Dukers DF; Chott A; Kazama Y; Oudejans JJ; van Berkum O; Kummer JA
    Blood; 2002 Jan; 99(1):232-7. PubMed ID: 11756176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.
    Bladergroen BA; Strik MC; Wolbink AM; Wouters D; Broekhuizen R; Kummer JA; Hack CE
    Eur J Immunol; 2005 Apr; 35(4):1175-83. PubMed ID: 15739160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites.
    Bladergroen BA; Strik MC; Bovenschen N; van Berkum O; Scheffer GL; Meijer CJ; Hack CE; Kummer JA
    J Immunol; 2001 Mar; 166(5):3218-25. PubMed ID: 11207275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus is present in neoplastic cytotoxic T cells in extranodal, and predominantly in B cells in nodal T non-Hodgkin lymphomas.
    Brink AA; ten Berge RL; van den Brule AJ; Willemze R; Chott A; Meijer CJ
    J Pathol; 2000 Aug; 191(4):400-6. PubMed ID: 10918215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
    Bossard C; Belhadj K; Reyes F; Martin-Garcia N; Berger F; Kummer JA; Brière J; Baglin AC; Cheze S; Bosq J; Ribrag V; Gisselbrecht C; Mounier N; Gaulard P
    Blood; 2007 Mar; 109(5):2183-9. PubMed ID: 17077322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
    Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
    Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granzyme B-expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization.
    de Bruin PC; Kummer JA; van der Valk P; van Heerde P; Kluin PM; Willemze R; Ossenkoppele GJ; Radaszkiewicz T; Meijer CJ
    Blood; 1994 Dec; 84(11):3785-91. PubMed ID: 7524749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of cytotoxic T-cell and natural killer cell lymphomas.
    Jaffe ES; Krenacs L; Raffeld M
    Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granzyme B immunoreactivity in T/natural killer cell lymphomas.
    Cho MS; Lee MK; Yang WI; Yoon JH
    Yonsei Med J; 1997 Oct; 38(5):285-93. PubMed ID: 9409191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells.
    Jiang X; Orr BA; Kranz DM; Shapiro DJ
    Endocrinology; 2006 Mar; 147(3):1419-26. PubMed ID: 16306080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma.
    Perambakam S; Naresh K; Nerurkar A; Nadkarni J
    Pathol Oncol Res; 2000; 6(2):114-7. PubMed ID: 10936786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
    Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
    Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphoma.
    Souza BMB; De Vito FB; Calado ML; Silva MV; Oliveira LR; Rodrigues-Júnior V; Moraes-Souza H
    Leuk Lymphoma; 2018 Jan; 59(1):214-220. PubMed ID: 28679297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.